Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test.
Bujanda L, Lanas Á, Quintero E, Castells A, Sarasqueta C, Cubiella J, Hernandez V, Morillas JD, Perez-Fernández T, Salas D, Andreu M, Carballo F, Bessa X, Cosme A, Jover R; COLONPREV Study Investigators. Bujanda L, et al. Among authors: bessa x. Mayo Clin Proc. 2013 Jul;88(7):683-9. doi: 10.1016/j.mayocp.2013.04.016. Epub 2013 Jun 7. Mayo Clin Proc. 2013. PMID: 23751980 Clinical Trial.
Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study.
Piñol V, Andreu M, Castells A, Payá A, Bessa X, Rodrigo J; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Piñol V, et al. Among authors: bessa x. Eur J Gastroenterol Hepatol. 2004 Jan;16(1):39-45. doi: 10.1097/00042737-200401000-00007. Eur J Gastroenterol Hepatol. 2004. PMID: 15095851
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Rodríguez-Moranta F, Payá A, Jover R, Bessa X; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Piñol V, et al. Among authors: bessa x. JAMA. 2005 Apr 27;293(16):1986-94. doi: 10.1001/jama.293.16.1986. JAMA. 2005. PMID: 15855432
Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
Llor X, Pons E, Xicola RM, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Roca A, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Llor X, et al. Among authors: bessa x. Clin Cancer Res. 2005 Oct 15;11(20):7304-10. doi: 10.1158/1078-0432.CCR-05-0965. Clin Cancer Res. 2005. PMID: 16243801
Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Piñol V, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Jover R, et al. Among authors: bessa x. Gut. 2006 Jun;55(6):848-55. doi: 10.1136/gut.2005.073015. Epub 2005 Nov 18. Gut. 2006. PMID: 16299036 Free PMC article.
120 results